» Articles » PMID: 27567818

Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2016 Aug 29
PMID 27567818
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, increasing attention has been given to the identification of the conversion of mild cognitive impairment (MCI) to Alzheimer's disease (AD). Brain neuroimaging techniques have been widely used to support the classification or prediction of MCI. The present study combined magnetic resonance imaging (MRI), 18F-fluorodeoxyglucose PET (FDG-PET), and 18F-florbetapir PET (florbetapir-PET) to discriminate MCI converters (MCI-c, individuals with MCI who convert to AD) from MCI non-converters (MCI-nc, individuals with MCI who have not converted to AD in the follow-up period) based on the partial least squares (PLS) method. Two types of PLS models (informed PLS and agnostic PLS) were built based on 64 MCI-c and 65 MCI-nc from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. The results showed that the three-modality informed PLS model achieved better classification accuracy of 81.40%, sensitivity of 79.69%, and specificity of 83.08% compared with the single-modality model, and the three-modality agnostic PLS model also achieved better classification compared with the two-modality model. Moreover, combining the three modalities with clinical test score (ADAS-cog), the agnostic PLS model (independent data: florbetapir-PET; dependent data: FDG-PET and MRI) achieved optimal accuracy of 86.05%, sensitivity of 81.25%, and specificity of 90.77%. In addition, the comparison of PLS, support vector machine (SVM), and random forest (RF) showed greater diagnostic power of PLS. These results suggested that our multimodal PLS model has the potential to discriminate MCI-c from the MCI-nc and may therefore be helpful in the early diagnosis of AD.

Citing Articles

Comparative Diagnostic Performance of Amyloid-β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head-to-Head Meta-Analysis.

Li F, Cheng J, Jin K, Zhao L, Li J, Wu J Brain Behav. 2024; 14(10):e70111.

PMID: 39435676 PMC: 11494400. DOI: 10.1002/brb3.70111.


Expression of regional brain amyloid-β deposition with Flutemetamol in Centiloid scale -a multi-site study.

Bao Y, Wang Z, Guo L, Bai G, Feng Y, Zhao G Neuroradiology. 2024; 66(9):1537-1551.

PMID: 38676749 DOI: 10.1007/s00234-024-03364-5.


Feature Importance Analysis and Machine Learning for Alzheimer's Disease Early Detection: Feature Fusion of the Hippocampus, Entorhinal Cortex, and Standardized Uptake Value Ratio.

Hassouneh A, Bazuin B, Danna-Dos-Santos A, Acar I, Abdel-Qader I Digit Biomark. 2024; 8(1):59-74.

PMID: 38650695 PMC: 11034932. DOI: 10.1159/000538486.


Multimodal classification of Alzheimer's disease and mild cognitive impairment using custom MKSCDDL kernel over CNN with transparent decision-making for explainable diagnosis.

Adarsh V, Gangadharan G, Fiore U, Zanetti P Sci Rep. 2024; 14(1):1774.

PMID: 38245656 PMC: 10799876. DOI: 10.1038/s41598-024-52185-2.


Amyloid-β PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis.

Ruan D, Sun L Brain Behav. 2022; 13(1):e2850.

PMID: 36573329 PMC: 9847612. DOI: 10.1002/brb3.2850.